# Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial

> Research article (Neuro-Oncology, 2020) · cited 28× · AI/ML

**Wikidata**: [openalex:W3043182175](https://www.wikidata.org/wiki/openalex:W3043182175)  
**Source**: https://4ort.xyz/entity/value-of-dynamic-contrast-perfusion-mri-to-predict-early-response-to-bevacizumab-in-newly-diagnosed-glioblastoma-results